Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Leukemia · 2025 · PMC12208870 · PMID 40275069

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendp = 0.11not close (p > 0.1)

did not reach statistical significanceno p-value reported

The number of prior lines showed a trend toward an increased occurrence of t-MN (HR 1.11; 95% CI 0.98–1.25, p = 0.11), though this did not reach statistical significance at the 0.05 level.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.